BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 14734567)

  • 1. Threonine 98, the pivotal residue of tissue inhibitor of metalloproteinases (TIMP)-1 in metalloproteinase recognition.
    Lee MH; Rapti M; KnaĆ¼per V; Murphy G
    J Biol Chem; 2004 Apr; 279(17):17562-9. PubMed ID: 14734567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delineating the molecular basis of the inactivity of tissue inhibitor of metalloproteinase-2 against tumor necrosis factor-alpha-converting enzyme.
    Lee MH; Rapti M; Murphy G
    J Biol Chem; 2004 Oct; 279(43):45121-9. PubMed ID: 15308656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unveiling the surface epitopes that render tissue inhibitor of metalloproteinase-1 inactive against membrane type 1-matrix metalloproteinase.
    Lee MH; Rapti M; Murphy G
    J Biol Chem; 2003 Oct; 278(41):40224-30. PubMed ID: 12869573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein engineering of the tissue inhibitor of metalloproteinase 1 (TIMP-1) inhibitory domain. In search of selective matrix metalloproteinase inhibitors.
    Wei S; Chen Y; Chung L; Nagase H; Brew K
    J Biol Chem; 2003 Mar; 278(11):9831-4. PubMed ID: 12515831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Constraining specificity in the N-domain of tissue inhibitor of metalloproteinases-1; gelatinase-selective inhibitors.
    Hamze AB; Wei S; Bahudhanapati H; Kota S; Acharya KR; Brew K
    Protein Sci; 2007 Sep; 16(9):1905-13. PubMed ID: 17660250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Residue 2 of TIMP-1 is a major determinant of affinity and specificity for matrix metalloproteinases but effects of substitutions do not correlate with those of the corresponding P1' residue of substrate.
    Meng Q; Malinovskii V; Huang W; Hu Y; Chung L; Nagase H; Bode W; Maskos K; Brew K
    J Biol Chem; 1999 Apr; 274(15):10184-9. PubMed ID: 10187802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Total conversion of tissue inhibitor of metalloproteinase (TIMP) for specific metalloproteinase targeting: fine-tuning TIMP-4 for optimal inhibition of tumor necrosis factor-{alpha}-converting enzyme.
    Lee MH; Rapti M; Murphy G
    J Biol Chem; 2005 Apr; 280(16):15967-75. PubMed ID: 15713681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. E. coli expression of TIMP-4 and comparative kinetic studies with TIMP-1 and TIMP-2: insights into the interactions of TIMPs and matrix metalloproteinase 2 (gelatinase A).
    Troeberg L; Tanaka M; Wait R; Shi YE; Brew K; Nagase H
    Biochemistry; 2002 Dec; 41(50):15025-35. PubMed ID: 12475252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix metalloproteinase-10 (MMP-10) interaction with tissue inhibitors of metalloproteinases TIMP-1 and TIMP-2: binding studies and crystal structure.
    Batra J; Robinson J; Soares AS; Fields AP; Radisky DC; Radisky ES
    J Biol Chem; 2012 May; 287(19):15935-46. PubMed ID: 22427646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Directed evolution of the metalloproteinase inhibitor TIMP-1 reveals that its N- and C-terminal domains cooperate in matrix metalloproteinase recognition.
    Raeeszadeh-Sarmazdeh M; Greene KA; Sankaran B; Downey GP; Radisky DC; Radisky ES
    J Biol Chem; 2019 Jun; 294(24):9476-9488. PubMed ID: 31040180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reactive site mutations in tissue inhibitor of metalloproteinase-3 disrupt inhibition of matrix metalloproteinases but not tumor necrosis factor-alpha-converting enzyme.
    Wei S; Kashiwagi M; Kota S; Xie Z; Nagase H; Brew K
    J Biol Chem; 2005 Sep; 280(38):32877-82. PubMed ID: 16079149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix metalloproteinase expression and activity following prostaglandin F(2 alpha)-induced luteolysis.
    Ricke WA; Smith GW; Smith MF
    Biol Reprod; 2002 Mar; 66(3):685-91. PubMed ID: 11870075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thermodynamic Basis of Selectivity in the Interactions of Tissue Inhibitors of Metalloproteinases N-domains with Matrix Metalloproteinases-1, -3, and -14.
    Zou H; Wu Y; Brew K
    J Biol Chem; 2016 May; 291(21):11348-58. PubMed ID: 27033700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase.
    Bigg HF; Morrison CJ; Butler GS; Bogoyevitch MA; Wang Z; Soloway PD; Overall CM
    Cancer Res; 2001 May; 61(9):3610-8. PubMed ID: 11325829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structure of the catalytic domain of matrix metalloproteinase-1 in complex with the inhibitory domain of tissue inhibitor of metalloproteinase-1.
    Iyer S; Wei S; Brew K; Acharya KR
    J Biol Chem; 2007 Jan; 282(1):364-71. PubMed ID: 17050530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The activity of a designer tissue inhibitor of metalloproteinases (TIMP)-1 against native membrane type 1 matrix metalloproteinase (MT1-MMP) in a cell-based environment.
    Lee MH; Atkinson S; Rapti M; Handsley M; Curry V; Edwards D; Murphy G
    Cancer Lett; 2010 Apr; 290(1):114-22. PubMed ID: 19815335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic changes in the expression of matrix metalloproteinases and their inhibitors, TIMPs, during hepatic fibrosis induced by alcohol in rats.
    Xu GF; Li PT; Wang XY; Jia X; Tian DL; Jiang LD; Yang JX
    World J Gastroenterol; 2004 Dec; 10(24):3621-7. PubMed ID: 15534918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metalloproteinase and inhibitor expression profiling of resorbing cartilage reveals pro-collagenase activation as a critical step for collagenolysis.
    Milner JM; Rowan AD; Cawston TE; Young DA
    Arthritis Res Ther; 2006; 8(5):R142. PubMed ID: 16919164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolution of matrix metalloprotease and tissue inhibitor expression during heart failure progression in the infarcted rat.
    Peterson JT; Li H; Dillon L; Bryant JW
    Cardiovasc Res; 2000 May; 46(2):307-15. PubMed ID: 10773235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered balance between matrix metalloproteinases and their inhibitors in experimental biliary fibrosis.
    Kossakowska AE; Edwards DR; Lee SS; Urbanski LS; Stabbler AL; Zhang CL; Phillips BW; Zhang Y; Urbanski SJ
    Am J Pathol; 1998 Dec; 153(6):1895-902. PubMed ID: 9846979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.